Turning catalytically inactive human Argonaute proteins into active slicer enzymes

Nat Struct Mol Biol. 2013 Jul;20(7):814-7. doi: 10.1038/nsmb.2577. Epub 2013 May 12.

Abstract

Argonaute proteins interact with small RNAs that guide them to complementary target RNAs, thus leading to inhibition of gene expression. Some but not all Argonaute proteins are endonucleases and can cleave the complementary target RNA. Here, we have mutated inactive human Ago1 and Ago3 and generated catalytic Argonaute proteins. We find that two short sequence elements at the N terminus are important for activity. In addition, PIWI-domain mutations in Ago1 may misarrange the catalytic center. Our work helps in understanding of the structural requirements that make an Argonaute protein an active endonucleolytic enzyme.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Amino Acid Substitution
  • Argonaute Proteins / chemistry*
  • Argonaute Proteins / genetics
  • Argonaute Proteins / metabolism
  • Base Sequence
  • Catalysis
  • Eukaryotic Initiation Factors / chemistry*
  • Eukaryotic Initiation Factors / genetics
  • Eukaryotic Initiation Factors / metabolism
  • HEK293 Cells
  • Humans
  • MicroRNAs / metabolism
  • Models, Molecular
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Point Mutation
  • Protein Conformation
  • Protein Structure, Tertiary
  • RNA Interference
  • RNA Processing, Post-Transcriptional
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / metabolism
  • Sequence Alignment
  • Sequence Homology, Amino Acid
  • Structure-Activity Relationship

Substances

  • AGO1 protein, human
  • AGO2 protein, human
  • AGO3 protein, human
  • AGO4 protein, human
  • Argonaute Proteins
  • Eukaryotic Initiation Factors
  • MicroRNAs
  • Recombinant Fusion Proteins